Literature DB >> 22983658

Outcomes of a group intensive peer-support model of case management for supported housing.

Jack Tsai1, Robert A Rosenheck.   

Abstract

OBJECTIVE: Community-based intensive case management may be more intense than necessary and may be socially isolating for persons living in supported housing. This study evaluated a group intensive peer-support (GIPS) model of case management that was implemented in a supported housing program for homeless veterans with a broad range of psychiatric,substance use, and general medical problems. Group meetings led by case managers are the default mode of case management support, and individual intensive case management is provided only when clinically necessary.
METHODS: GIPS was implemented by the U.S. Department of Housing and Urban Development–Veterans Affairs Supportive Housing(HUD-VASH) program at one demonstration site in April 2010. The study used administrative data to compare outcomes, service delivery, and timing of housing acquisition among clients of the demonstration site one year before (N=102) and after (N=167) GIPS implementation and among clients of other HUD-VASH sites across the country before (N=9,659) and after (N=21,318) implementation of GIPS at the demonstration site.
RESULTS: After adjustment for differences in baseline characteristics, the analyses found that GIPS implementation was associated with a greater increase in social integration ratings, a greater number of case manager services, and faster acquisition of Section 8 housing vouchers after program admission compared with outcomes at the same site before GIPS implementation and at the other sites before and after implementation.
CONCLUSIONS: GIPS may be a viable service model of supported housing that represents a recovery-oriented approach that can be scaled up to address homelessness.

Entities:  

Mesh:

Year:  2012        PMID: 22983658     DOI: 10.1176/appi.ps.201200100

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  7 in total

1.  Expanded Medicaid Provides Access to Substance Use, Mental Health, and Physician Visits to Homeless and Precariously Housed Persons.

Authors:  R David Parker; Michael J Cima; Zachary Brown; Michael Regier
Journal:  J Community Health       Date:  2018-04

Review 2.  Risk factors for homelessness among US veterans.

Authors:  Jack Tsai; Robert A Rosenheck
Journal:  Epidemiol Rev       Date:  2015-01-16       Impact factor: 6.222

3.  Diversion of Veterans With Criminal Justice Involvement to Treatment Courts: Participant Characteristics and Outcomes.

Authors:  Jack Tsai; Bessie Flatley; Wesley J Kasprow; Sean Clark; Andrea Finlay
Journal:  Psychiatr Serv       Date:  2016-12-01       Impact factor: 3.084

4.  Racial Differences in Chronic Conditions and Sociodemographic Characteristics Among High-Utilizing Veterans.

Authors:  Jessica Y Breland; Christine Pal Chee; Donna M Zulman
Journal:  J Racial Ethn Health Disparities       Date:  2014-11-08

5.  Identifying variability in permanent supportive housing: A comparative effectiveness approach to measuring health outcomes.

Authors:  Julia Dickson-Gomez; Katherine Quinn; Arturo Bendixen; Amy Johnson; Kelly Nowicki; Thant Ko Ko; Carol Galletly
Journal:  Am J Orthopsychiatry       Date:  2017-03-16

6.  The comparative effectiveness of different models of permanent supportive housing on problematic substance use, depression, and anxiety symptoms over time.

Authors:  Julia Dickson-Gomez; Timothy McAuliffe; Katherine Quinn; Antoinette Spector; Peter Toepfer; Arturo Bendixen; Wayne DiFranceisco
Journal:  Am J Orthopsychiatry       Date:  2021-05-03

7.  The impact of a short-term cohousing initiative among schizophrenia patients, high school students, and their social context: A qualitative case study.

Authors:  Domingo Palacios-Ceña; Emilio Andrés Martín-Tejedor; Ana Elías-Elispuru; Amaia Garate-Samaniego; Jorge Pérez-Corrales; Elena García-García
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.